| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/05/2002 | US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders |
| 12/05/2002 | US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer |
| 12/05/2002 | US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020183485 Nucleotide sequences coding receptor protein for use in the treatment of hypertriglyceridaemia, inflammation, cachexia, infections and tumors |
| 12/05/2002 | US20020183484 Immunogenic formulation and process for preparation thereof |
| 12/05/2002 | US20020183390 Administration of a D-serine transport inhibitor (serine dodecylamide, alanine dodecylamide or glycyldodecylamide) sufficient to enhance (N-methyl-D-aspartate) receptor mediated neurotransmission in vivo for psychological disorder |
| 12/05/2002 | US20020183379 Kits for determining risk of Alzheimer's disease |
| 12/05/2002 | US20020183314 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 12/05/2002 | US20020183276 Administering alkaline phosphatase (TNAP) inhibitor to the tissue or patient effective to inhibit TNAP expression or activity for decreasing matrix mineralization in a tissue |
| 12/05/2002 | US20020183269 Novel compounds |
| 12/05/2002 | US20020183250 For use in therapy of sleep disorders |
| 12/05/2002 | US20020182767 Process for preparing a hydrogen sensor |
| 12/05/2002 | US20020182752 Analyzing an antigen or antibody in a sample; obtain antibody/antigen sample, incubate with latex particles, monitor turbity and latex agglutination |
| 12/05/2002 | US20020182751 Sperm cell selection system |
| 12/05/2002 | US20020182748 Method and device for testing for Bence-Jones Protein |
| 12/05/2002 | US20020182743 Surface plasmon resonance |
| 12/05/2002 | US20020182742 Examination method of buffer capacity of saliva and examination instrument of buffer capacity of saliva |
| 12/05/2002 | US20020182739 Rapid detection of aromas using integrated gas chromatography with multiarray sensors |
| 12/05/2002 | US20020182736 Measurement of lipid oxidation activity in sample; obtain lipid sample, incubate with radical generator, expose to indicator, measure oxidation of indicator |
| 12/05/2002 | US20020182725 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 12/05/2002 | US20020182718 Method and device for the handling of samples and reagents |
| 12/05/2002 | US20020182717 Method of preparing supported lipid film membranes and use thereof |
| 12/05/2002 | US20020182715 Microarray for use in the detection of therapeutic compounds in herbs |
| 12/05/2002 | US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins |
| 12/05/2002 | US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 12/05/2002 | US20020182701 Dominant negative variants of methionine aminopeptidase 2 (MetAP2) and clinical uses thereof |
| 12/05/2002 | US20020182698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 12/05/2002 | US20020182691 Nucleotide sequences coding transport protein for use in nervous system disorders |
| 12/05/2002 | US20020182683 Vascular endothelial growth factor 2 |
| 12/05/2002 | US20020182681 Peptide for use in treatment of cancer, parkinson's and metabolic disorders |
| 12/05/2002 | US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia |
| 12/05/2002 | US20020182671 Polypeptide for use in the treatment, diagnosis, and prevention of cell proliferative, autoimmune/inflammatory, neurological and gatrointestinal disorders |
| 12/05/2002 | US20020182662 Positive response biosensors and other sensors |
| 12/05/2002 | US20020182661 Substrate analogs for MurG, methods of making same and assays using same |
| 12/05/2002 | US20020182660 Diagnosing alzheimer's disease in humans; obtain sample containing amyloid peptides, incubate with antibodies, presence of preferential peptide indicates alzheimer's disease |
| 12/05/2002 | US20020182658 Seamless apparatus for use in the detection of preferential particles in sample |
| 12/05/2002 | US20020182657 Pathogen detection system for drinking water |
| 12/05/2002 | US20020182656 Methods for regulating vascularization using GEF containing NEK-like kinase (GNK) |
| 12/05/2002 | US20020182655 Method for identifying ligands for G protein-coupled receptors |
| 12/05/2002 | US20020182654 Cell isolation method and uses thereof |
| 12/05/2002 | US20020182653 Detection of preferential antigen in sample; obtain tissue, transfer to glass slide, soak tissue, heat, destroy aldehyde bridges, evaluate antigen activation |
| 12/05/2002 | US20020182652 Detection of preferential protein in sample; obtain sample of protein mixture, incubate with probe, detect signal from probes |
| 12/05/2002 | US20020182651 Protein profiling platform |
| 12/05/2002 | US20020182650 Inhibitors of binding between proteins and macromolecular ligands |
| 12/05/2002 | US20020182649 Detection of preferential protein in sample; obtain target protein, generate protein cleavage products, detect products, compare to control |
| 12/05/2002 | US20020182647 Histoscreen method |
| 12/05/2002 | US20020182646 Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders |
| 12/05/2002 | US20020182645 Separation of preferential cells in sample; obtain cells, incubate with label, separate labeled cells, recover cells |
| 12/05/2002 | US20020182644 Diagnosing alzheimers in humans; obtain cerbrospinal fluid, detect preferential marker, presence of marker indicates alzheimers disease |
| 12/05/2002 | US20020182643 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell |
| 12/05/2002 | US20020182642 Biosensors and methods of using the same |
| 12/05/2002 | US20020182641 Detection of endotoxin concentration in sample; obtain sample containing adenosine receptor, incubate with binding agent, monitor displacement of binding agent |
| 12/05/2002 | US20020182640 Immunological analyzing apparatus and immunological analyzing method |
| 12/05/2002 | US20020182639 Synthetic peptides for cartilage resorption assays |
| 12/05/2002 | US20020182638 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020182637 Analysis of crystals; form solid suport, obtain mother liquor, crystalize, image drops from mother liquor |
| 12/05/2002 | US20020182635 Methods of screening for LTRPC2 modulators |
| 12/05/2002 | US20020182634 Detection of varicella-zoster virus |
| 12/05/2002 | US20020182633 Methods of patterning protein and cell adhesivity |
| 12/05/2002 | US20020182632 Inorganic particle conjugates |
| 12/05/2002 | US20020182631 Apparatus for us for use in the analysis and detection of preferential particles in solution |
| 12/05/2002 | US20020182629 Flexible substrate for microarray assays |
| 12/05/2002 | US20020182627 Biochips including ion transport detecting strucutres and methods of use |
| 12/05/2002 | US20020182626 Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications |
| 12/05/2002 | US20020182624 Chemokine receptors and disease |
| 12/05/2002 | US20020182623 Reagent and process for the identification and counting of biological cells |
| 12/05/2002 | US20020182621 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders |
| 12/05/2002 | US20020182619 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
| 12/05/2002 | US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020182617 Binding assay using binding agents with tail groups |
| 12/05/2002 | US20020182614 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 12/05/2002 | US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect |
| 12/05/2002 | US20020182608 Providing a device for detecting presence of target nucleic acid molecule; contacting probes with sample which may have target nucleic acid molecule under selective hybridization conditions, determining if electrical current can be carried |
| 12/05/2002 | US20020182603 Uniformly functionalized surfaces for microarrays |
| 12/05/2002 | US20020182602 Biopolymer for use in the detection of preerential sequences in sample |
| 12/05/2002 | US20020182597 Used for screening for protein-compound interactions such as protein- therapeutic compound interactions |
| 12/05/2002 | US20020182594 Chemomagnetic retrieval of CMV and CMV infected cells |
| 12/05/2002 | US20020182592 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 12/05/2002 | US20020182591 Monitoring wound heating agent; obtain cell culture, insert into holding apparatus, expose culture to electrode, monitor activity of cell culture |
| 12/05/2002 | US20020182590 Monitoring polypeptide activation; obtain nucleotide sequences, incubate with cells, monitor phenotypic expression, associate phenotypic expression with protein |
| 12/05/2002 | US20020182588 Induction of apoptosis by cellular stress |
| 12/05/2002 | US20020182587 Detection of modulators of cell proliferation; obtain cells, monitor cell proliferation, incubate cell with modulator, detect adjustment in cell proliferation |
| 12/05/2002 | US20020182586 Novel compositions and methods for cancer |
| 12/05/2002 | US20020182585 Therapeutic treatment for vascular defects |
| 12/05/2002 | US20020182231 Methods of stem cell manipulation for immunotherapy |
| 12/05/2002 | US20020182215 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 12/05/2002 | US20020182210 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 12/05/2002 | US20020182207 Contacting said target molecule with a catalyst capable of chemically modifying said target molecule; catalyzing the attachment of the label to the target substance |
| 12/05/2002 | US20020182206 Treating an inflammatory disease by administrating a therapeutically effective amount of a PRO301, PRO362 or PRO245 antagonist, or fragment thereof. |
| 12/05/2002 | US20020182197 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby |
| 12/05/2002 | US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin |
| 12/05/2002 | US20020182169 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 12/05/2002 | US20020182153 Method for detecting chitin-containing organisms |
| 12/05/2002 | US20020182152 Ocular diagnosis of Alzheimer's Disease |
| 12/05/2002 | US20020182150 Quantitative analysis; infrared analyzing; labeling animal;s with laser dyes |
| 12/05/2002 | US20020182149 Radiation transparent strip with adhesive surface; measuring efficiency of antiaging cosmetics |
| 12/05/2002 | US20020182117 Determination target compounds; immobilization |
| 12/05/2002 | US20020182116 Housing for receptacle filling |